Literature DB >> 28245998

History and epidemiology of anabolic androgens in athletes and non-athletes.

Gen Kanayama1, Harrison G Pope2.   

Abstract

The use of androgens, frequently referred to as anabolic-androgenic steroids (AAS), has grown into a worldwide substance abuse problem over the last several decades. Testosterone was isolated in the 1930s, and numerous synthetic androgens were quickly developed thereafter. Athletes soon discovered the dramatic anabolic effects of these hormones, and AAS spread rapidly through elite athletics and bodybuilding from the 1950s through the 1970s. However it was not until the 1980s that widespread AAS use emerged from the elite athletic world and into the general population. Today, the great majority of AAS users are not competitive athletes, but instead are typically young to middle-aged men who use these drugs primarily for personal appearance. AAS abuse has now become particularly prevalent in regions such as Scandinavia, the United States, Brazil, and British Commonwealth countries, but remains rare in countries such as China, Korea, and Japan - a pattern that reflects cultural differences in attitudes towards male muscularity.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Anabolic-androgenic steroids; Androgens; Epidemiology; History; Men; Testosterone

Mesh:

Substances:

Year:  2017        PMID: 28245998     DOI: 10.1016/j.mce.2017.02.039

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  23 in total

1.  Severe and protracted cholestasis in 44 young men taking bodybuilding supplements: assessment of genetic, clinical and chemical risk factors.

Authors:  Andrew Stolz; Victor Navarro; Paul H Hayashi; Robert J Fontana; Huiman X Barnhart; Jiezhun Gu; Naga P Chalasani; Maricruz M Vega; Herbert L Bonkovsky; Leonard B Seeff; Jose Serrano; Bharathi Avula; Ikhlas A Khan; Elizabeth T Cirulli; David E Kleiner; Jay H Hoofnagle
Journal:  Aliment Pharmacol Ther       Date:  2019-04-01       Impact factor: 8.171

Review 2.  Supraphysiologic-dose anabolic-androgenic steroid use: A risk factor for dementia?

Authors:  Marc J Kaufman; Gen Kanayama; James I Hudson; Harrison G Pope
Journal:  Neurosci Biobehav Rev       Date:  2019-02-25       Impact factor: 8.989

Review 3.  Public health impact of androgens.

Authors:  Gen Kanayama; Marc J Kaufman; Harrison G Pope
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2018-06       Impact factor: 3.243

Review 4.  Diagnosis and Management of Anabolic Androgenic Steroid Use.

Authors:  Bradley D Anawalt
Journal:  J Clin Endocrinol Metab       Date:  2019-07-01       Impact factor: 5.958

Review 5.  The medicalization of testosterone: reinventing the elixir of life.

Authors:  Thiago Gagliano-Jucá; Mauricio Alvarez; Shehzad Basaria
Journal:  Rev Endocr Metab Disord       Date:  2022-08-23       Impact factor: 9.306

Review 6.  Understanding and managing the suppression of spermatogenesis caused by testosterone replacement therapy (TRT) and anabolic-androgenic steroids (AAS).

Authors:  Ankit Desai; Musaab Yassin; Axel Cayetano; Tharu Tharakan; Channa N Jayasena; Suks Minhas
Journal:  Ther Adv Urol       Date:  2022-06-26

7.  Anabolic-androgenic steroids and cognitive effort discounting in male rats.

Authors:  Lisa B Dokovna; Grace Li; Ruth I Wood
Journal:  Horm Behav       Date:  2019-05-08       Impact factor: 3.587

8.  Anabolic-androgenic steroid administration increases self-reported aggression in healthy males: a systematic review and meta-analysis of experimental studies.

Authors:  Razieh Chegeni; Ståle Pallesen; Jim McVeigh; Dominic Sagoe
Journal:  Psychopharmacology (Berl)       Date:  2021-03-20       Impact factor: 4.530

Review 9.  Review Article: Anabolic-Androgenic Steroids, Violence, and Crime: Two Cases and Literature Review.

Authors:  Harrison G Pope; Gen Kanayama; James I Hudson; Marc J Kaufman
Journal:  Am J Addict       Date:  2021-04-19

Review 10.  Harm Reduction in Male Patients Actively Using Anabolic Androgenic Steroids (AAS) and Performance-Enhancing Drugs (PEDs): a Review.

Authors:  Alex K Bonnecaze; Thomas O'Connor; Cynthia A Burns
Journal:  J Gen Intern Med       Date:  2021-05-04       Impact factor: 6.473

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.